Download App

Log in to access Online Inquiry
Company Overview More
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company’s product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; HTX-019, an investigational agent for the prevention of postoperative nausea and vomiting; and HTX-034 for postoperative pain management, as well as is in Phase Ib/II clinical study in patients undergoing bunionectomy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
CEO: Quart Pharm.D., Barry D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > HRTX Heron Therapeutics > Detailed Quotes

HRTX Heron Therapeutics

3.555-0.045-1.25%
Trading Session 05/23 10:34 ET
High
3.660
Open
3.640
Turnover
1.32M
Low
3.460
Pre Close
3.600
Volume
373.82K
Market Cap
364.31M
P/E(TTM)
Loss
52wk High
16.630
Shares
102.48M
P/E(Static)
Loss
52wk Low
3.120
Float Cap
275.82M
Bid/Ask %
2.33%
Historical High
830.000
Shs Float
77.59M
Volume Ratio
1.08
Historical Low
2.002
Dividend TTM
--
Div Yield TTM
95
P/B
15.19
Dividend LFY
--
Div Yield LFY
2672.29%
Turnover Ratio
0.48%
Amplitude
5.56%
Avg Price
3.532
Lot Size
1
Float Cap
275.82M
Bid/Ask %
2.33%
Historical High
830.000
Shs Float
77.59M
Volume Ratio
1.08
Historical Low
2.002
Dividend TTM
--
P/B
15.19
Dividend LFY
--
Turnover Ratio
0.48%
Amplitude
5.56%
Avg Price
3.532
Lot Size
1
Price Forecast

No Data

News

Comment